The 'Sports Illustrated Swimsuit' model previously admitted to micro-dosing the weight loss drug in her sibling series, 'Love ...

The Trump administration is expected to announce a deal with two major drug companies to lower the price of their weight-loss drugs. The deal would reduce the costs of the lowest doses of Zepbound and ...

Trump administration negotiating with Novo Nordisk and Eli Lilly to lower Wegovy, Zepbound prices to $149/month, with some Medicare coverage.

Novo Nordisk stock was rising after it posted quarterly earnings. The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.